DS2 designer pre-fusion F vaccine induces strong and protective antibody response against RSV infection
Abstract DS-Cav1, SC-TM, and DS2 are distinct designer pre-fusion F proteins (pre-F) of respiratory syncytial virus (RSV) developed for vaccines. However, their immunogenicity has not been directly compared. In this study, we generated three recombinant vaccines using the chimpanzee adenovirus vecto...
Saved in:
Main Authors: | Yiling Yang, Ruoke Wang, Fenglin Guo, Tian Zhao, Yuqing Lei, Qianqian Yang, Yige Zeng, Ziqing Yang, Tatchapon Ajavavarakula, Ruijie Tan, Mingxi Li, Haodi Dong, Mengyue Niu, Keyan Bao, Hao Geng, Qining Lv, Qi Zhang, Xuanling Shi, Peng Liu, Jiwan Ge, Xinquan Wang, Linqi Zhang |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Portfolio
2024-12-01
|
Series: | npj Vaccines |
Online Access: | https://doi.org/10.1038/s41541-024-01059-9 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The recent landscape of RSV vaccine research
by: Karen Kelleher, et al.
Published: (2025-01-01) -
The Use of Albuterol in Young Infants Hospitalized with Acute RSV Bronchiolitis
by: Michael T. Del Vecchio, et al.
Published: (2012-01-01) -
Immunogenicity of RSV F DNA Vaccine in BALB/c Mice
by: Erdal Eroglu, et al.
Published: (2016-01-01) -
The Role of RSV Infection in Asthma Initiation and Progression: Findings in a Mouse Model
by: Junyan Han, et al.
Published: (2011-01-01) -
Leveraging Real-World Evidence to Define Severe RSV Lower Respiratory Tract Disease in Adults
by: Catherine A. Panozzo, et al.
Published: (2024-11-01)